DecisionDx-Melanoma resources: Educational and clinical support
Hear from experts and patients alike and learn more about DecisionDx-Melanoma’s precise, personalized and proven results.
Expert opinions on the treatment
and management of cutaneous melanoma
Explore case studies
View real-world examples of how gene expression profile (GEP) testing with DecisionDx-Melanoma can help guide risk-aligned care for patients diagnosed with cutaneous melanoma
Hear a patient's journey with DecisionDx-Melanoma
As a stage III melanoma survivor, Morgan speaks on how important it is to be your own advocate. After her diagnosis, she requested the DecisionDx-Melanoma test from her doctor for the additional information it can provide. The results she received from her DecisionDx-Melanoma test report continue to help reduce her anxiety and provide confidence about her future.
Order the DecisionDx-Melanoma test
Explore on-demand webinars
Incorporating prognostic gene expression profiling in the management of skin cancer
Faculty: Shannon Trotter, DO Oakview Dermatology
James Sligh, MD, PhD – Bay Pines VA Medical Center
CME/CE: CME (1.0 AMA PRA Category 1 Credit(s))
Use of a genomic-based prognostic tool to inform clinical decisions for patients with cutaneous melanoma
Faculty: Shannon Trotter, DO
Oakview DermatologyJoseph Michael Guenther, MD
St. Elizabeth Physicians
CME/CE: CME (Credit Expiration Date: July 31, 2021)
Incorporating DecisionDx-Melanoma into clinical practice: molecular information for personalized management decisions
Faculty: Darrell S. Rigel, MD, FAAD – Clinical Professor of Dermatology, New York University Grossman Medical School
CME/CE: N/A
Castle Biosciences - revolutionizing gene expression profiling in clinical management of dermatologic cancers
Faculty: Aarron Farberg, MD, FAAD – Baylor University Medical Center, Dallas, TX
CME/CE: N/A
31-GEP: sentinel lymph node biopsy guidance
Faculty: John Vetto, MD, FACS
CME/CE: N/A
DecisionDx-Melanoma: predicting individualized risk of recurrence
Faculty: James Sligh, MD, PhD
CME/CE: N/A
